Sangamo Therapeutics Inc (SGMO) Q4 2025 Earnings Call Highlights: Strategic Advances and ... [Yahoo! Finance]
Sangamo Therapeutics, Inc. (SGMO)
Last sangamo therapeutics, inc. earnings: 2/28 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.sangamo.com
Company Research
Source: Yahoo! Finance
Funding Raised: Over $130 million in funding through non-dilutive license fees, milestone payments, and equity financing since the start of 2025. Clinical Progress: Rolling submission of a Biologics License Agreement (BLA) to the FDA for ST-920, with non-clinical and clinical modules submitted. Fast Track Designation: Received for SC503, an investigational epigenetic regulator for Fabry disease with intractable pain due to small fiber neuropathy. Clinical Sites Activated: Six clinical sites activated for the Phase I/II STAN study in chronic neuropathic pain. Manufacturing Milestones: Completion of manufacturing and testing of process validation lots with acceptable results; first commercial lot manufactured. Warning! GuruFocus has detected 6 Warning Signs with SGMO. Is SGMO fairly valued? Test your thesis with our free DCF calculator. Release Date: March 30, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript Posi
Show less
Read more
Impact Snapshot
Event Time:
SGMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SGMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SGMO alerts
High impacting Sangamo Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SGMO
News
- ???????????2035????702.2???????????????(CAGR)22.78%??? [CNET News]CNET News
- Sangamo Therapeutics Reports Recent Business Highlights And Fourth Quarter And Full Year 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
- Sangamo Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Sangamo Therapeutics Reports Recent Business Highlights And Fourth Quarter And Full Year 2025 Financial ResultsGlobeNewswire
- Here are the major earnings after the close Monday [Seeking Alpha]Seeking Alpha
SGMO
Earnings
- 3/30/26 - Miss
SGMO
Analyst Actions
- 2/10/26 - HC Wainwright
SGMO
Sec Filings
- 3/30/26 - Form 10-K
- 3/30/26 - Form 8-K
- 2/26/26 - Form 4
- SGMO's page on the SEC website